Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Clinical Genitourinary Cancer
|
March 27, 2026
Monitoring of Disease in Patients Receiving <sup>177</sup>LU-PSMA-617 Therapy in Routine Practice
Narmeen S Rashid, Caiwei Zhong, Wanling Xie, et al.
Prostate Cancer and Prostatic Diseases
|
November 18, 2025
Publisher Correction: Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer
Autumn Gagnon, Caiwei Zhong, Wanling Xie, et al.
Prostate Cancer and Prostatic Diseases
|
October 28, 2025
Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer
Autumn Gagnon, Caiwei Zhong, Wanling Xie, et al.
JCO Oncology Practice
|
April 24, 2026
Efficacy and Safety of 177Lu-PSMA-617 in Elderly Patients With Metastatic Castration-Resistant Prostate Cancer
Daniel Sentana-Lledo, Avina Rami, Caiwei Zhong, et al.
Cancers
|
June 26, 2025
Race and Outcomes to [<sup>177</sup>Lu]Lu-PSMA-617 in Advanced Prostate Cancer
Avina Rami, Caiwei Zhong, Miguel Muniz, et al.
European Urology Oncology
|
November 15, 2024
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer
Praful Ravi, Caiwei Zhong, Wanling Xie, et al.
European Urology Focus
|
December 8, 2024
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma
Justine Panian, Caiwei Zhong, Sharon H Choi, et al.
Nature Medicine
|
January 7, 2026
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma
Carolina Alves Costa Silva, Marc Machaalani, Renee Maria Saliby, et al.
JACC. Cardiooncology
|
March 21, 2024
Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study
Amin H Nassar, Edward El-Am, Ryan Denu, et al.
Journal for Immunotherapy of Cancer
|
March 6, 2024
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes
Amin H Nassar, Talal El Zarif, Ahmed Bilal Khalid, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Clinical Genitourinary Cancer
|
March 27, 2026
Monitoring of Disease in Patients Receiving <sup>177</sup>LU-PSMA-617 Therapy in Routine Practice
Narmeen S Rashid, Caiwei Zhong, Wanling Xie, et al.
Prostate Cancer and Prostatic Diseases
|
November 18, 2025
Publisher Correction: Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer
Autumn Gagnon, Caiwei Zhong, Wanling Xie, et al.
Prostate Cancer and Prostatic Diseases
|
October 28, 2025
Testosterone suppression and recovery with abiraterone/prednisone monotherapy after early discontinuation of LHRH-A in hormone sensitive prostate cancer
Autumn Gagnon, Caiwei Zhong, Wanling Xie, et al.
JCO Oncology Practice
|
April 24, 2026
Efficacy and Safety of 177Lu-PSMA-617 in Elderly Patients With Metastatic Castration-Resistant Prostate Cancer
Daniel Sentana-Lledo, Avina Rami, Caiwei Zhong, et al.
Cancers
|
June 26, 2025
Race and Outcomes to [<sup>177</sup>Lu]Lu-PSMA-617 in Advanced Prostate Cancer
Avina Rami, Caiwei Zhong, Miguel Muniz, et al.
European Urology Oncology
|
November 15, 2024
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer
Praful Ravi, Caiwei Zhong, Wanling Xie, et al.
European Urology Focus
|
December 8, 2024
Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma
Justine Panian, Caiwei Zhong, Sharon H Choi, et al.
Nature Medicine
|
January 7, 2026
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma
Carolina Alves Costa Silva, Marc Machaalani, Renee Maria Saliby, et al.
JACC. Cardiooncology
|
March 21, 2024
Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study
Amin H Nassar, Edward El-Am, Ryan Denu, et al.
Journal for Immunotherapy of Cancer
|
March 6, 2024
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes
Amin H Nassar, Talal El Zarif, Ahmed Bilal Khalid, et al.
Page
of 1